No major side-effects of Hydroxychloroquine (HCQ) have been found in studies in India and its use should be continued in preventive treatment for COVID-19, the Indian Council of Medical Research (ICMR) said on Tuesday.
The ICMR’s statement came against the backdrop of the World Health Organization (WHO) suspending the testing of the drug in COVID-19 patients temporarily in its global study following safety concerns.
“We found there were no major side affects except for nausea, vomiting, palpitation occasionally. Hence in our advisory we have recommended that it should be continued for prophylaxis as there is no harm. Benefit may be there,” ICMR Director General Balram Bhargava said. (AGENCIES)
Tag :
health
'Red' heat wave alert in North India: Best foods to eat during a heatwave
Novavax has begun the first phase of the trial in which 131 volunteers in the cities of Melbourne and Brisbane will test the safety of the vaccine and look for early signs of the vaccine's effectivene
From a genetic error that makes people more vulnerable, to how the disease is worse for patients in the US, ThePrint brings you the latest research on the Covid-19 front.
No major side-effects of HCQ, should be continued as preventive treatment for COVID-19: ICMR
The globalisation of pharmaceuticals and what some see as an over-reliance on products from China and India has been criticised in the US, the UK and the European Union.
At least 24 COVID-19 patients die at Nashik hospital after oxygen tanker leak
